From JP Morgan to the next wave: What's driving biotech in 2026

This webinar brings together leaders from across disciplines to explore the evolving forces shaping biotech’s future—from capital trends and dealmaking to innovative pipelines and strategic partnerships. This forward-looking discussion will offer insights into how companies can navigate an increasingly complex clinical and commercialization landscape, leveraging precise, data-driven approaches to access innovation and accelerate the delivery of new medicines to patients.

Specific topics of discussion will include:

• How JP Morgan 2026’s tone sets expectations for biotech’s trajectory in the coming year
• Challenges and strategies in translating early-stage science into commercially viable products
• The impact of real-world data and AI on development and commercialization strategies
• Defining what a successful molecule-to-market strategy looks like in today’s climate